Rybelsus 3 Mg 10 Tablets

Rybelsus 3 Mg 10 Tablets

Description:

Rybelsus 3 mg is an oral prescription diabetes medicine containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, used to improve blood sugar control in adults with type 2 diabetes mellitus. It is the first tablet form of a GLP-1 analog, designed to help lower blood glucose levels by enhancing glucose-dependent insulin secretion, reducing inappropriate glucagon release, and slowing gastric emptying. Rybelsus 3 mg is typically used as the initial starting dose before increasing to higher strengths, as part of a comprehensive diabetes management plan that includes diet, exercise, and regular medical follow-up.

Indications:

• Type 2 diabetes mellitus in adults to improve glycemic control.
• Helps reduce elevated fasting and postprandial blood glucose levels.
• May be used as monotherapy when metformin is not tolerated or contraindicated, or in combination with other oral antidiabetic medicines or insulin (as directed by a physician).
• Assists in long-term diabetes management to help reduce the risk of complications associated with poorly controlled blood sugar, such as cardiovascular, renal, and neuropathic complications (as part of overall medical care).

Active Ingredients / Key Components:

• Semaglutide – 3 mg per tablet.
• Excipients (tablet core and coating) – include standard pharmaceutical tablet ingredients such as fillers, binders, and stabilizers (exact excipient list and concentrations , please check the product leaflet or the manufacturer’s official website; refer to the official package leaflet for full details).

Dosage & Administration / How to Use:

• Usual starting dose: 3 mg semaglutide orally once daily for 30 days, as directed by the prescribing physician. This starting dose is not intended for long-term maintenance but to help the body adjust to treatment.
• After at least 30 days on 3 mg, the dose is usually increased to 7 mg once daily. If additional glycemic control is needed, the dose may be further increased to 14 mg once daily, based on medical advice.
• Take Rybelsus once daily on an empty stomach with a small amount of water (up to 120 ml). Swallow the tablet whole; do not split, crush, or chew.
• Take at least 30 minutes before eating, drinking (other than up to 120 ml plain water), or taking any other oral medicines to ensure proper absorption.
• Try to take the tablet at the same time each day for consistent effect.
• If a dose is missed, skip the missed dose and take the next dose at the usual time the following day. Do not take an extra tablet to make up for a missed dose.
• Use only under medical supervision, especially when used with other antidiabetic medicines or insulin, as dose adjustments of concomitant therapy may be required to reduce the risk of hypoglycemia.

Clinical Benefits:

• Improves glycemic control in adults with type 2 diabetes by enhancing glucose-dependent insulin secretion and reducing inappropriate glucagon secretion.
• Helps lower fasting and post-meal blood sugar levels, supporting better long-term HbA1c control when combined with diet and exercise.
• Oral GLP-1 receptor agonist option for patients who prefer tablets over injectable GLP-1 therapies, improving treatment convenience and potential adherence.
• Slows gastric emptying, which contributes to reduced postprandial glucose spikes and may support reduced appetite and caloric intake.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to semaglutide or any of the excipients.
• Not indicated for use in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
• Use with caution in patients with a history of pancreatitis; discontinue and seek medical attention if severe, persistent abdominal pain occurs.
• Use with caution in patients with severe gastrointestinal disease, including severe gastroparesis, as GLP-1 agonists delay gastric emptying.
• May increase the risk of hypoglycemia when used in combination with insulin or sulfonylureas; dose adjustment of concomitant therapy may be required.
• Patients with renal or hepatic impairment should use under close medical supervision; dose adjustments may be required based on clinical response and tolerability.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Use during pregnancy or lactation only if clearly needed and prescribed by a physician.
• Consult your doctor before use if you have a history of thyroid disease, pancreatitis, severe gastrointestinal disorders, or other serious medical conditions.
• Not intended for use in children and adolescents; safety and efficacy in patients under 18 years have not been established.
• Do not share this prescription medicine with others, even if they have similar symptoms.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, vomiting, diarrhea, abdominal pain, decreased appetite, indigestion, and constipation. These are often mild to moderate and may decrease over time as the body adjusts.
• Other possible side effects include headache, fatigue, and mild weight loss.
• Serious but less common side effects may include pancreatitis (severe, persistent abdominal pain that may radiate to the back, with or without vomiting), severe allergic reactions (rash, itching, swelling, difficulty breathing), or significant dehydration due to prolonged vomiting or diarrhea.
• Seek immediate medical attention if you experience symptoms of pancreatitis, severe abdominal pain, signs of allergic reaction, or persistent severe gastrointestinal symptoms.
• This is not a complete list of side effects. Always review the patient information leaflet and consult your healthcare provider if you notice any unusual or bothersome symptoms.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at room temperature as indicated on the official package leaflet, and protect from excessive moisture.

Specifications:

• Form: Tablet.
• Strength: 3 mg semaglutide per tablet.
• Pack size: 10 tablets per pack.
• Route of administration: Oral.
• Intended use: Prescription medicine for adults with type 2 diabetes mellitus.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.